![IJMS | Free Full-Text | Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL IJMS | Free Full-Text | Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL](https://www.mdpi.com/ijms/ijms-22-09388/article_deploy/html/images/ijms-22-09388-g001.png)
IJMS | Free Full-Text | Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL
![Combining hypertonic stress with Bcl-xL inhibition drives HNSCC cells... | Download Scientific Diagram Combining hypertonic stress with Bcl-xL inhibition drives HNSCC cells... | Download Scientific Diagram](https://www.researchgate.net/publication/344016879/figure/fig1/AS:1025343502696448@1621472349628/Combining-hypertonic-stress-with-Bcl-xL-inhibition-drives-HNSCC-cells-into-apoptosis.png)
Combining hypertonic stress with Bcl-xL inhibition drives HNSCC cells... | Download Scientific Diagram
![Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer | Infectious Agents and Cancer | Full Text Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer | Infectious Agents and Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1750-9378-9-44/MediaObjects/13027_2014_Article_516_Fig1_HTML.jpg)
Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer | Infectious Agents and Cancer | Full Text
![Cell apoptosis regulated by Bcl-x isoforms. a. Three modes that had... | Download Scientific Diagram Cell apoptosis regulated by Bcl-x isoforms. a. Three modes that had... | Download Scientific Diagram](https://www.researchgate.net/publication/352356792/figure/fig1/AS:1033924373405696@1623518188695/Cell-apoptosis-regulated-by-Bcl-x-isoforms-a-Three-modes-that-had-been-proposed-to.png)
Cell apoptosis regulated by Bcl-x isoforms. a. Three modes that had... | Download Scientific Diagram
Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy | ACS Nano
![BCL-XL expression is essential for human erythropoiesis and engraftment of hematopoietic stem cells | Cell Death & Disease BCL-XL expression is essential for human erythropoiesis and engraftment of hematopoietic stem cells | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-019-2203-z/MediaObjects/41419_2019_2203_Fig1_HTML.png)
BCL-XL expression is essential for human erythropoiesis and engraftment of hematopoietic stem cells | Cell Death & Disease
![ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ] ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2013/144/1/fig-8-full.png)
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
![Bcl‐xL sequesters its C‐terminal membrane anchor in soluble, cytosolic homodimers | The EMBO Journal Bcl‐xL sequesters its C‐terminal membrane anchor in soluble, cytosolic homodimers | The EMBO Journal](https://www.embopress.org/cms/asset/b11c1ffe-bf7e-4077-b673-18ddefb1ba1c/embj7600225-fig-0002-m.jpg)
Bcl‐xL sequesters its C‐terminal membrane anchor in soluble, cytosolic homodimers | The EMBO Journal
![A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2010.18/MediaObjects/41419_2010_Article_BFcddis201018_Fig1_HTML.jpg)
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
![Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation | Journal of Experimental & Clinical Cancer Research | Full Text Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02001-w/MediaObjects/13046_2021_2001_Fig1_HTML.png)
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation | Journal of Experimental & Clinical Cancer Research | Full Text
![Anti‐apoptotic genes Bcl‐2 and Bcl‐xL overexpression can block iridovirus serine/threonine kinase‐induced Bax/mitochondria‐mediated cell death in GF‐1 cells | Semantic Scholar Anti‐apoptotic genes Bcl‐2 and Bcl‐xL overexpression can block iridovirus serine/threonine kinase‐induced Bax/mitochondria‐mediated cell death in GF‐1 cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9fe3f3fe6f94cd87ad8eeea6373c50d0a0e4a2c0/8-Figure8-1.png)
Anti‐apoptotic genes Bcl‐2 and Bcl‐xL overexpression can block iridovirus serine/threonine kinase‐induced Bax/mitochondria‐mediated cell death in GF‐1 cells | Semantic Scholar
![BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells | Cell Death & Disease BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-2589-7/MediaObjects/41419_2020_2589_Fig1_HTML.png)
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells | Cell Death & Disease
![Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition | Journal of Medicinal Chemistry Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00517/asset/images/large/jm1c00517_0010.jpeg)